News - Page 246 - Psychedelic Alpha

Our 🎯 Q1 2026 Psychedelic Pipeline Bullseye Charts are now available.

Read more about the article Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Psychedelic Bulletin: Decrim Ambitions Spread to NJ and CA; Compass Shows Strong Cash Position; Cybin and Entheon Go Public

Post published:November 13, 2020
Post category:Psychedelic Bulletin

Read more about the article MindMed Announces Q3 2020 Financial Results

MindMed Announces Q3 2020 Financial Results

Post published:November 13, 2020
Post category:Press Release

Read more about the article Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Silo Wellness Announces the First-of-Its-Kind U.S.-Legal Psychedelic Wellness Nature Retreat in Oregon

Post published:November 13, 2020
Post category:Press Release

Read more about the article Mind Cure Announces Non-Brokered Private Placement of $3 Million

Mind Cure Announces Non-Brokered Private Placement of $3 Million

Post published:November 13, 2020
Post category:Press Release

Read more about the article European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives

European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives

Post published:November 12, 2020
Post category:Press Release

Read more about the article Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Tryp Appoints Dr. Jim Gilligan, PhD, MBIS, as President and Chief Scientific Officer

Post published:November 12, 2020
Post category:Press Release

Read more about the article Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange

Entheon Biomedical Corp. Commences Trading on the Canadian Securities Exchange

Post published:November 12, 2020
Post category:Press Release

Read more about the article Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications

Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications

Post published:November 12, 2020
Post category:Press Release

Read more about the article COMPASS Pathways plc announces financial results for third quarter 2020

COMPASS Pathways plc announces financial results for third quarter 2020

Post published:November 12, 2020
Post category:Press Release

NeonMind Obtains Health Canada Approval to Advance Psilocybin Research

Post published:November 12, 2020
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond. Psy Alpha Ltd is a company registered in England and Wales (16989109).

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.